Antibody-therapeutic agent conjugates

Details Antibody-therapeutic agent conjugates Antibody-therapeutic agent conjugates

1984-09-13

1989-09-19

Teskin, Robin L.

Drug, bio-affecting and body treating compositions

Lymphokine

424 858, 424 86, 424 87, 530387, 530388, 530389, 530390, 530391, 530828, 514 2, 514 6, 514 8, A61K 3900, A61K 3700, A23J 3700

Patent

active

048679739

ABSTRACT:
This invention relates to antibody-therapeutic agent conjugates having a therapeutic agent covalently attached to an antibody or antibody fragment. Also described are methods for intermediates in the preparation of antibody conjugates. Therapeutic in vivo methods utilizing such antibody-therapeutic agent conjugates are described.

REFERENCES:
patent: 3970521 (1976-07-01), Zaborsky et al.
patent: 4093607 (1978-06-01), Sela et al.
patent: 4167449 (1979-09-01), Gargiulo et al.
patent: 4217338 (1980-08-01), Ouash
patent: 4256833 (1981-03-01), Ali et al.
patent: 4263279 (1981-04-01), Sela etal.
patent: 4287345 (1981-09-01), Kotani et al.
patent: 4419444 (1983-12-01), Ouash
patent: 4671958 (1987-06-01), Rodwell et al.
Monsigny et al, FEBS Letters, vol. 119 (1), Sep. 1980, pp. 181-186, "Preparation and Biological Properties of a Covalent Antitumor Drug-Arm-Carrier", CDAC Conjugate).
Trovet et al., Proc Natl Acad Sci, Jan. 1982, vol. 79, pp. 626-629, "A Covalent Linkage Between Davnorubicon and Proteins That is Stable in Serum and Reversible by Lysosumal Protease as Required for a Lysosomotropol Drug-Carrier Conjugate: In Vitro and In Vivo Studies".
Paul, Fundamental Immunology, 1984, pp. 132, 149.
March, Advanced Organic Chemistry, 2nd Ed, 1972, pp. 824-827.
Anderson and Parrish, Science 220: 524-527 (1983).
Bale et al., Cancer Research 40: 2965-2972 (1980).
Bing, Biochemistry 8: 4503-4510 (1969).
Blythman et al, Nature 290: 145-146 (1981).
Bunton, in Oxidation in Organic Chemistry, vol. I, Widberg, ed., Academic Press, New York, p. 365 (1965).
Caporale et al., J. Immunol. 126: 1963-1965 (1981).
Cooper, Biochemistry 14: 4245-4251 (1975).
Cooper et al., J. Biol. Chem. 234: 445-448 (1959).
Davis and Preston, Science 213: 1358-1388 (1981).
Dougherty et al., in Porphyrin Photosensitization, Kessel and Dougherty eds., Plenum Publishing Corp., New York, (1983) pp. 3-13.
Ghose et al., J. Natl. Cancer Inst. 61(3): 657-676 (1978).
Gregoriadis, Pharmac. Ther. 10: 103-118 (1980).
Gregoriadis, Nature 265: 407-411 (1977).
Heath et al., Biochim Biophys. Acta. 640: 66-81 (1981).
Huang et al., J. Biol. Chem. 255(17): 8015-8018 (1980).
Hurwitz et al., Int. J. Cancer 24: 461-470 (1979).
Jackson, "Periodic Acid Oxidations" in Organic Reactions, vol. 2, pp. 341-375 (1944).
Jentoff and Dearborn, J. Biol. Chem. 254: 4359-4365 (1979).
Lesserman et al., Nature 288: 602-604 (1980).
March, in Advanced Organic Chemistry: Reactions, Mechanisms and Structures, McGraw Hill Co., New York, pp. 824-825 (1978).
Martin et al., Biochem 20: 4229-4238 (1981).
Mew et al., J. Immunol. 130: 1473-1477 (1983).
Mitra and Lawton, J. Amer. Chem. Soc. 101: 3097-3110 (1979).
Murayama et al., Immunochem. 15: 523-528 (1978).
Parrish, J. Investig. Dermatol. 77: 45-50 (1981).
Reid and Porter, Ann. Rev. Biochem 50: 433-464 (1981).
Rowland, in Targeted Drugs, Goldberg ed., Interscience Publications, New York, pp. 57-72 (1983).
Sim et al., Biochem. J. 163: 219-227 (1977).
Stanworth and Turner, in Handbook of Experimental Immunology, vol. I, 2d ed. Weir, ed. Blackwell Scientific Publications, London, Chapter 10 (1973).
Willan et al., FEBS Lett. 80: 133-136 (1977).

Affiliated with

Also associated with

Rating

Antibody-therapeutic agent conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibody-therapeutic agent conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody-therapeutic agent conjugates will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-367650